NASDAQ: CJETChijet Motor Company Inc Stock
$1.74-0.18 (-9.38%)
Updated May 9, 2025
CJET Price
$1.74
Fair Value Price
N/A
Market Cap
$9.54M
52 Week Low
$1.09
52 Week High
$23.95
P/E
-0.19x
P/B
-0.06x
P/S
6.1x
PEG
N/A
Dividend Yield
N/A
Revenue
$10.28M
Earnings
-$49.91M
Gross Margin
-268.4%
Operating Margin
-332.48%
Profit Margin
-485.7%
Debt to Equity
-3.95
Operating Cash Flow
-$29M
Beta
0.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CJET Overview
Jupiter Wellness Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare industry. Jupiter Wellness Acquisitionwas incorporated in 2021 and is based in Jupiter, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CJET's potential to beat the market
- CJET doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Auto
Industry Rating
F
CJET
RankedUnranked of 21
RankedUnranked of 21
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $3.35 | C | |
| $37.94 | C | |
| $488.28 | C |
Be the first to know about important CJET news, forecast changes, insider trades & much more!
CJET News
Overview
Due Diligence Score
–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CJET scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CJET is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CJET is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CJET's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CJET due diligence checks available for Premium users.
Valuation
CJET price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.19x
Industry
95.77x
Market
24.88x
CJET price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.06x
Industry
2.56x
CJET's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CJET's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CJET's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$500.3M
Liabilities
$608.7M
Debt to equity
-3.95
CJET's short-term liabilities ($523.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CJET's long-term liabilities ($85.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CJET's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CJET's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
CJET's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CJET vs Auto Stocks
Chijet Motor Company Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.